Search results for "chronic urticaria"

showing 10 items of 32 documents

Urticaria in Pediatrics and During Pregnancy and Lactation: Highlights on Epidemiology, Diagnosis, and Management

2021

Chronic urticaria (CU) in children as in adults is characterized by the presence of itchy wheals, angioedema, or both daily or almost daily for at least 6 weeks. Most cases of urticaria in the pediatric age group are acute [1–4]. CU is sub-classified as spontaneous (occurring without a known trigger) or inducible. There are also cases of spontaneous and inducible forms that co-exist. The chronic subtypes occur continuously but also recurrently, often in association with infections. In this chapter we will touch briefly on the clinical presentation, diagnosis, and management of acute urticaria in children. However, our primary goal is to highlight key findings regarding the epidemiology, dia…

PregnancyPediatricsmedicine.medical_specialtyAcute urticariaAngioedemabusiness.industryPediatric agemedicine.diseasemedicine.anatomical_structureimmune system diseasesLactationEpidemiologyMedicineApproaches of managementmedicine.symptomskin and connective tissue diseasesbusinessChronic urticaria
researchProduct

Relationship between quality of life and anxiety aspects in chronic spontaneous urticaria

2019

Introduction: Clinical experience indicates the role of the psychological component in chronic spontaneous urticaria (CSU). The CSU can lead to psychological disturbances. This phenomenon results in a possible quality of life impairment among CSU patients. Aim: To analyse in detail the quality of life parameters and anxiety aspects in relation to CSU duration and symptom intensity. Material and methods: The patient sample was composed of 67 CSU subjects. For the quality of life and mental status assessment, all subjects were questionnaired with CU-Q2 oL and State and Trait Anxiety Inventory (STAI). In the control group, 42 healthy volunteers were enrolled to fill in the STAI questionnaire. …

business.industryDermatologySTAIanxietychronic urticariaCU-Q2oLQuality of life (healthcare)quality of lifeImmunology and AllergyMedicineAnxietymedicine.symptombusinessChronic urticariaClinical psychologyPostępy Dermatologii I Alergologii
researchProduct

Comment on “Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab”

2020

medicine.medical_specialty2019-20 coronavirus outbreakUrticariaCoronavirus disease 2019 (COVID-19)ExacerbationSARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Symptom Flare UpTreatment outcomeMEDLINECOVID-19OmalizumabDermatologyOmalizumabInternal medicineAnti-Allergic AgentsCorrespondenceHumansMedicineChronic Urticariabusinessmedicine.drugInternational Journal of Dermatology
researchProduct

High prevalence and little awareness in patients with chronic inflammatory skin diseases and genital involvement.

2020

Background Genital involvement in patients with chronic inflammatory skin diseases is frequent, yet insufficiently acknowledged. Objective To evaluate the prevalence of genital symptoms in psoriasis and chronic urticaria patients, effects on quality of life, physician-patient relations and disease management. Patients and methods 100 patients with psoriasis and 100 with chronic urticaria from our outpatient clinic, as well as 50 healthy controls were included. Data was collected using questionnaires developed by dermatological experts. Results Out of 250 subjects, 74 % had already experienced genital symptoms - 70 % of psoriasis patients and 58 % of urticaria patients. Seven out of ten even…

medicine.medical_specialtyHigh prevalenceUrticariabusiness.industry610 MedizinDermatologymedicine.diseaseDermatologyQuality of lifePsoriasis610 Medical sciencesChronic DiseasemedicinePrevalenceQuality of LifeOutpatient clinicHumansPsoriasisSex organIn patientGenitaliaDisease management (health)skin and connective tissue diseasesbusinessChronic urticariaJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGReferences
researchProduct

Does adiponectin play a role in the pathogenesis of chronic spontaneous urticaria?

2020

Introduction Chronic spontaneous urticaria constitutes an interdisciplinary problem and its pathogenesis is still a subject of debate. Overweight and hyperlipidemia are supposed to be related to chronic spontaneous urticaria. Fatty tissue can be the source of adipokines. Aim of the study To assess the potential role of adiponectin in chronic spontaneous urticaria pathogenesis. Material and methods The study included 52 chronic spontaneous urticaria patients and 43 healthy controls. The patients were divided into two subgroups: patients with wheals only, and patients with urticaria and an accompanying angioedema. The adiponectin concentration was measured in all studied subjects. Results No …

medicine.medical_specialtyImmunologylcsh:MedicineAdipose tissueAdipokineOverweightGastroenterologychronic urticariaPathogenesisimmune system diseasesInternal medicineHyperlipidemiaparasitic diseasesmedicineImmunology and Allergyskin and connective tissue diseasesadipokinesAdiponectinAngioedemaadiponectinbusiness.industrypathogenesislcsh:RSignificant differencemedicine.diseaseClinical Immunologymedicine.symptombusinessmetabolismCentral-European Journal of Immunology
researchProduct

Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity

2005

Summary Background  Chronic urticaria (CU), one of the most common skin disorders, is characterized by spontaneous recurrent bouts of weals and pruritus and associated with severely impaired quality of life (QoL). Objectives  To determine what aspects of life quality are affected and to characterize the factors that impact on QoL in CU patients. Subjects and methods  This interdisciplinary interview/questionnaire-based study included 100 patients admitted to a University Hospital Dermatology Department for the identification of underlying causes of CU; 96 healthy subjects matched for age and sex were used as controls. QoL was assessed using Skindex-29, a validated instrument to measure the …

medicine.medical_specialtyPsychometricsbusiness.industryDermatologyDiseasehumanities3. Good health030207 dermatology & venereal diseases03 medical and health sciencesPsychiatric comorbidity0302 clinical medicineQuality of lifeInternal medicinePhysical therapymedicineAnxietyIn patient030212 general & internal medicinemedicine.symptombusinessChronic urticariaDepression (differential diagnoses)British Journal of Dermatology
researchProduct

Management of chronic urticaria in children: a clinical guideline

2019

Abstract The aim of this guidance is to provide recommendations to clinicians and other interested parties on chronic urticaria in children. The Italian Society for Pediatrics (SIP), the Italian Society for Allergy and Immunology (SIAIP), the Italian Society for Pediatric dermatology (SIDerP) convened a multidisciplinary panel that prepared clinical guidelines for diagnosis and management of chronic urticaria in childhood. Key questions on epidemiology, natural history, diagnosis, and management were developed. The literature was systematically searched and evaluated, recommendations were rated and algorithms for diagnosis and treatment were developed. The recommendations focus on identific…

medicine.medical_specialtyUrticariaAllergyReviewPathogenesisOmalizumabOmalizumab03 medical and health sciences0302 clinical medicinePathogenesiMultidisciplinary approach030225 pediatricsEpidemiologymedicineHumans030212 general & internal medicineAngioedemaPediatric dermatologyChildChildrenChronic urticariaPediatricAngioedemabusiness.industrylcsh:RJ1-570lcsh:PediatricsGeneral MedicineGuidelineChronic urticariaChronic spontaneous urticariaSettore MED/38ManagementNatural historyInducible uricariaItalyFamily medicineTherapymedicine.symptombusinessmedicine.drugItalian Journal of Pediatrics
researchProduct

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study

2021

Background: Ligelizumab, a next-generation, humanized anti-immunoglobulin E (IgE) monoclonal antibody is in development as a treatment for patients with chronic spontaneous urticaria, whose symptoms are inadequately controlled with standard-of-care therapy. Objective: To evaluate the long-term safety and re-treatment efficacy of ligelizumab 240 mg in patients who completed the core study and extension study. Methods: This open-label, single-arm, long-term Phase 2b extension study was designed to assess patients who were previously administered various doses of ligelizumab, omalizumab or placebo in the Phase 2b, dose-finding core study and who presented with active disease after Week 32. In …

medicine.medical_specialtyUrticariaImmunologyLigelizumab610OmalizumabOmalizumabImmunoglobulin EPlaceboAntibodies Monoclonal HumanizedInternal medicineActive diseasemedicineImmunology and AllergyHumansIn patientChronic UrticariaAdverse effectbiologybusiness.industryExtension studyChronic spontaneous urticariaTreatment OutcomeLigelizumabbiology.proteinIgEbusiness600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheitmedicine.drug
researchProduct

Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: Preliminary data.

2020

medicine.medical_specialtyUrticariabusiness.industryDermatologyGeneral MedicineOmalizumabOmalizumabReal world evidenceTreatment Outcomeclinical evaluation and treatmentAnti-Allergic AgentsChronic DiseasemedicineHumansChronic UrticariaIntensive care medicinebusinessdermatologic therapymedicine.drugPreliminary DataDermatologic therapyREFERENCES
researchProduct

Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA<sup>2</sup>LEN – ARIA Position Paper

2012

Concepts of disease severity, activity, control and responsiveness to treatment are linked but different. Severity refers to the loss of function of the organs induced by the disease process or to the occurrence of severe acute exacerbations. Severity may vary over time and needs regular follow-up. Control is the degree to which therapy goals are currently met. These concepts have evolved over time for asthma in guidelines, task forces or consensus meetings. The aim of this paper is to generalize the approach of the uniform definition of severe asthma presented to WHO for chronic allergic and associated diseases (rhinitis, chronic rhinosinusitis, chronic urticaria and atopic dermatitis) in …

medicine.medical_specialtybusiness.industryPublic healthImmunologymacromolecular substancesGeneral MedicineAtopic dermatitismedicine.disease3. Good health03 medical and health sciences0302 clinical medicine030228 respiratory systemDisease severityEpidemiologyImmunologymedicinePhysical therapyImmunology and AllergyPosition paperDisease process030212 general & internal medicineIntensive care medicinebusinessChronic urticariaAsthmaInternational Archives of Allergy and Immunology
researchProduct